November 10, 2020
Ono Pharmaceutical said on November 9 that it has commenced a PIII clinical study in Japan for its pancreatitis drug Foipan Tablets (camostat mesilate), a proteinase inhibitor, for the treatment of COVID-19. The study will enroll 110 asymptomatic or mildly...read more